Predictors of anemia associated with pegylated interferon and ribavirin combination therapy in patients with chronic hepatitis C
碩士 === 中國醫藥大學 === 臨床醫學研究所碩士班 === 99 === Background and Aims: The current treatment of choice for chronic hepatitis C is the combination of pegylated interferon and ribavirin. One major side effect of combination antiviral therapy is anemia that will influence life quality and usually needs dose redu...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2011
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/22079445753437626076 |